The T393C polymorphism of the Galphas gene (GNAS1) is associated with the course of Graves' disease.
Genotypes of the T393C SNP of GNAS1, a gene that encodes for the Galphas subunit of G proteins have been significantly associated with the clinical course in a variety of cancers. Since this SNP may also influence the course of Graves' disease (GD) and, especially, Graves' ophthalmopathy (GO), we determined genotype and allele frequency in a series of 359 patients, which were referred to our clinic within 6 months of the onset of GO. Among them, 336 patients also suffered from associated hyperthyroidism. Data on relapse and remission rates 12 months after termination of a 1 year antithyroid drug therapy was available for 276 patients. As controls, 820 healthy individuals were recruited. Our data suggest that the T393C SNP does not represent a risk factor for the development of both GD and GO. It was, however, significantly associated with the course of hyperthyroidism (p=0.013) and a similar trend was evident for the course of GO (p=0.093). Homozygous TT carriers showed a significantly increased risk (p=0.03) for hyperthyroidism to relapse (OR 2.4; 95% CI 1.1-5.4). Also, the TT genotype was associated with significantly increased serum TRAb levels (CC+CT: 5.4 IU/l vs. TT: 9.3 IU/l). This is probably caused by increased G-Protein susceptibility to TSHR-mediated stimulation through TRAb. Genotyping of the T393C SNP of GNAS1 may become a useful additional tool to predict the clinical course of GD and GO. This may allow the clinician to identify patients at risk for more severe courses of disease and to come to more timely decisions for treatment.
Glowacka
D
D
Department of Ophthalmology, University Hospital of Essen, University of Duisburg-Essen, Germany.
Loesch
C
C
Johnson
K T M
KT
Mann
K
K
Esser
J
J
Morgenthaler
N G
NG
Siffert
W
W
Schmid
K W
KW
Eckstein
A K
AK
D002864:Chromogranins; D015331:Cohort Studies; D005260:Female; D019205:GTP-Binding Protein alpha Subunits, Gs / Q000235:genetics*; D006111:Graves Disease / Q000188:drug therapy / Q000235:genetics*; D049970:Graves Ophthalmopathy / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy / Q000235:genetics; D008297:Male; D020641:Polymorphism, Single Nucleotide
D002864:Chromogranins; C406732:GNAS protein, human; D019205:GTP-Binding Protein alpha Subunits, Gs